Residual amounts of ophthalmic viscosurgical devices on the corneal endothelium following phacoemulsification.
Yoshino
Mami
M
Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan. mamiyoshino@tdc.ac.jp.|Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 Misaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan. mamiyoshino@tdc.ac.jp.
Bissen-Miyajima
Hiroko
H
Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.
Ohki
Shinichi
S
Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.
D000818:Animals; D002807:Chondroitin / Q000009:adverse effects; D002809:Chondroitin Sulfates; D004338:Drug Combinations; D004728:Endothelium, Corneal / Q000187:drug effects*; D006820:Hyaluronic Acid / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D018918:Phacoemulsification; D013552:Swine; D055682:Viscoelastic Substances / Q000009:adverse effects*
D004338:Drug Combinations; D009883:Ophthalmic Solutions; D055682:Viscoelastic Substances; C501944:chondroitin sulfate, sodium hyaluronate drug combination; D006820:Hyaluronic Acid; D002807:Chondroitin; D002809:Chondroitin Sulfates